Gastrointestinal stromal tumour in neurofibromatosis 1: 18F FDG PET/CT imaging

FDG-PET and PET/CT have demonstrated their clinical utility in discriminating between benign PNF and MPNST based on maximal standard uptake values. 3 Learning points There is a need for close tumour surveillance in the neurofibromatosis type 1 (NF1) population.

Saved in:
Bibliographic Details
Published inBMJ case reports Vol. 2016
Main Authors Sugrue, Gavin, Nguyen, Ba D
Format Journal Article
LanguageEnglish
Published England BMJ Publishing Group LTD 16.08.2016
BMJ Publishing Group
Subjects
Fluorodeoxyglucose F18
Gastrointestinal Neoplasms - complications
Gastrointestinal Neoplasms - diagnostic imaging
Gastrointestinal Stromal Tumors - complications
Gastrointestinal Stromal Tumors - diagnostic imaging
Humans
Images In
Jejunal Neoplasms - complications
Jejunal Neoplasms - diagnostic imaging
Male
Middle Aged
Neurofibromatosis 1 - complications
Neurofibromatosis 1 - diagnostic imaging
Positron Emission Tomography Computed Tomography - methods
Radiopharmaceuticals
Tomography
Tumors
USA/Canada
White
Online AccessGet full text

Cover

More Information
Summary:FDG-PET and PET/CT have demonstrated their clinical utility in discriminating between benign PNF and MPNST based on maximal standard uptake values. 3 Learning points There is a need for close tumour surveillance in the neurofibromatosis type 1 (NF1) population.
Bibliography:ObjectType-Case Study-2
SourceType-Scholarly Journals-1
ObjectType-Feature-4
content type line 23
ObjectType-Report-1
ObjectType-Article-3
ISSN:1757-790X
DOI:10.1136/bcr-2016-217038